Published on
July 26, 2020
- 17:52 GMT
Spectral Analytics Announces Positive Results IN VITRO Research for the Upcoming Patient Trial for COVID-19 Treatment
MANHATTAN, NEW YORK, UNITED STATES, July 26, 2020 /EINPresswire.com/ -- New York-based biotech company, Spectral Analytics (“Spectral”), which is working with the FDA to seek approval to initiate patient trials for a potential treatment for COVID-19 …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
